Bayer to Spend $1 Billion on Drug Research and Development in the US
Introduction: Bayer AG, a German multinational pharmaceutical company, plans to invest $1 billion in drug research and development in the US as it seeks to double its sales in the country by the end of the decade. The company aims to build up its portfolio of new drugs to improve